Annexon (ANNX) Other Working Capital Changes (2019 - 2026)
Annexon's (ANNX) quarterly Other Working Capital Changes came in at -$605000.0 in Q1 2026, down 2850.0% year-on-year from $22000.0 in Q1 2025, and down 137.25% quarter-over-quarter from -$255000.0 in Q4 2025.
Annexon (ANNX) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Annexon's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$605000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 2850.0% year-over-year to -$605000.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 6.27% increase from a year earlier, with the FY2025 full-year figure at -$598000.0, down 299.33% from the prior year.
- Other Working Capital Changes retreated to -$605000.0 in Q1 2026 per ANNX's latest filing, from -$255000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.6 million in Q1 2024 and bottomed at -$2.8 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is -$255000.0 (2025), against an average of -$114294.1.
- Across the five-year window, Other Working Capital Changes surged 570.0% in 2024 and sank 2850.0% in 2026, its largest moves.
- Year by year, Other Working Capital Changes stood at $259000.0 in 2022, then slumped by 84.56% to $40000.0 in 2023, then jumped by 570.0% to $268000.0 in 2024, then plunged by 195.15% to -$255000.0 in 2025, then plunged by 137.25% to -$605000.0 in 2026.
- Per Business Quant, the three latest ANNX Other Working Capital Changes figures stand at -$605000.0 (Q1 2026), -$255000.0 (Q4 2025), and $999000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Annexon | 1.02 Bn | 798.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -605,000.00 |
| Mar 31, 2026 | -605,000.00 |
| Mar 31, 2026 | -605,000.00 |
| Dec 31, 2025 | -255,000.00 |
| Dec 31, 2025 | -255,000.00 |
| Dec 31, 2025 | -255,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Sep 30, 2025 | 999,000.00 |
| Jun 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -1.36 Mn |
| Mar 31, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Dec 31, 2024 | 268,000.00 |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |